2024 Q4 Form 10-Q Financial Statement
#000149315224043927 Filed on November 07, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
Revenue | $741.1K | $998.4K | $796.1K |
YoY Change | -3.0% | 25.41% | 155.72% |
Cost Of Revenue | $384.4K | $525.5K | $563.8K |
YoY Change | -31.95% | -6.79% | |
Gross Profit | $223.1K | $346.8K | $232.3K |
YoY Change | 11.98% | 49.27% | |
Gross Profit Margin | 30.1% | 34.74% | 29.18% |
Selling, General & Admin | $1.949M | $2.460M | |
YoY Change | -20.77% | 69.66% | |
% of Gross Profit | 562.0% | 1058.83% | |
Research & Development | $948.8K | $100.0K | |
YoY Change | 848.75% | 25.0% | |
% of Gross Profit | 273.57% | 43.04% | |
Depreciation & Amortization | $241.6K | $247.6K | |
YoY Change | -2.41% | ||
% of Gross Profit | 69.67% | 106.57% | |
Operating Expenses | $2.621M | $3.198M | $2.869M |
YoY Change | 11.84% | 11.49% | 87.53% |
Operating Profit | -$2.264M | -$2.725M | -$2.526M |
YoY Change | 13.72% | 7.87% | 107.36% |
Interest Expense | $30.46K | $90.00K | |
YoY Change | -66.16% | ||
% of Operating Profit | |||
Other Income/Expense, Net | $7.685K | $30.46K | $93.94K |
YoY Change | -48.68% | -67.57% | 2087.73% |
Pretax Income | -$2.695M | -$2.430M | |
YoY Change | 10.9% | 100.83% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$2.249M | -$2.686M | -$2.425M |
YoY Change | 14.21% | 10.74% | 100.71% |
Net Earnings / Revenue | -303.52% | -268.99% | -304.64% |
Basic Earnings Per Share | -$0.50 | -$0.70 | -$1.04 |
Diluted Earnings Per Share | -$0.50 | -$0.70 | -$1.04 |
COMMON SHARES | |||
Basic Shares Outstanding | 4.387M shares | 4.250M shares | 2.330M shares |
Diluted Shares Outstanding | 4.536M shares | 3.811M shares | 2.330M shares |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $3.989M | $190.0K | |
YoY Change | 1999.7% | -96.69% | |
Cash & Equivalents | $2.242M | $3.990M | $186.4K |
Short-Term Investments | |||
Other Short-Term Assets | $348.7K | $396.2K | $413.3K |
YoY Change | 5.15% | -4.14% | 177.52% |
Inventory | $701.3K | $738.8K | $965.1K |
Prepaid Expenses | |||
Receivables | $266.1K | $578.6K | $567.5K |
Other Receivables | $648.3K | $560.0K | |
Total Short-Term Assets | $4.062M | $6.479M | $2.692M |
YoY Change | 37.93% | 140.68% | -67.2% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $537.2K | $586.1K | $664.9K |
YoY Change | -9.15% | -11.85% | 59.83% |
Goodwill | |||
YoY Change | |||
Intangibles | $3.903M | $4.400M | $4.872M |
YoY Change | -19.67% | -9.69% | |
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $4.622M | $5.247M | $6.009M |
YoY Change | -21.42% | -12.68% | 207.76% |
TOTAL ASSETS | |||
Total Short-Term Assets | $4.062M | $6.479M | $2.692M |
Total Long-Term Assets | $4.622M | $5.247M | $6.009M |
Total Assets | $8.684M | $11.73M | $8.700M |
YoY Change | -1.62% | 34.77% | -14.36% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.834M | $3.630M | |
YoY Change | -49.47% | 855.26% | |
Accrued Expenses | $759.1K | $630.0K | |
YoY Change | 20.49% | -34.38% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Long-Term Debt Due | $499.6K | $340.0K | |
YoY Change | 46.94% | ||
Total Short-Term Liabilities | $4.403M | $5.679M | $6.846M |
YoY Change | -15.06% | -17.05% | 190.43% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $310.0K | |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | $97.84K | $310.0K | |
YoY Change | -68.44% | -88.12% | |
Total Long-Term Liabilities | $97.84K | $620.0K | |
YoY Change | -84.22% | -76.25% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.403M | $5.679M | $6.846M |
Total Long-Term Liabilities | $97.84K | $620.0K | |
Total Liabilities | $4.481M | $5.777M | $7.464M |
YoY Change | -21.02% | -22.61% | 50.37% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$56.90M | -$54.65M | -$44.23M |
YoY Change | 23.15% | 23.55% | 36.59% |
Common Stock | $48.07K | $43.78K | $23.30K |
YoY Change | 225.66% | 87.84% | -84.35% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $1.00 | $1.00 | $14.00 |
YoY Change | 0.0% | -92.86% | |
Treasury Stock Shares | |||
Shareholders Equity | $4.366M | $6.105M | $1.356M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $8.684M | $11.73M | $8.700M |
YoY Change | -1.62% | 34.77% | -14.36% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.249M | -$2.686M | -$2.425M |
YoY Change | 14.21% | 10.74% | 100.71% |
Depreciation, Depletion And Amortization | $241.6K | $247.6K | |
YoY Change | -2.41% | ||
Cash From Operating Activities | -$2.387M | -$1.312M | |
YoY Change | 81.98% | -30.73% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | ||
YoY Change | -100.0% | ||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $42.45K | ||
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | -$2.387M | -$1.312M | |
Cash From Investing Activities | |||
Cash From Financing Activities | $42.45K | ||
Net Change In Cash | -$2.315M | -$1.351M | |
YoY Change | 71.35% | -45.87% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.387M | -$1.312M | |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q3 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
1 | usd |
CY2024Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
578578 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
738789 | usd |
CY2024Q3 | INBS |
Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
|
648334 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
5776641 | usd |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
43775 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
61207017 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-54649965 | usd |
CY2024Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-496259 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6104567 | usd |
CY2024Q3 | us-gaap |
Minority Interest
MinorityInterest
|
-155325 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
5949242 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11725883 | usd |
CY2024Q3 | dei |
Trading Symbol
TradingSymbol
|
INBS | |
CY2024Q3 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.01 per share | |
CY2024Q3 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q3 | dei |
Entity File Number
EntityFileNumber
|
001-39825 | |
CY2024Q3 | dei |
Entity Registrant Name
EntityRegistrantName
|
Intelligent Bio Solutions Inc. | |
CY2024Q3 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2024Q3 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
82-1512711 | |
CY2024Q3 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
Intelligent Bio Solutions Inc | |
CY2024Q3 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
135 West, 41ST Street | |
CY2024Q3 | dei |
Entity Address Address Line3
EntityAddressAddressLine3
|
5th Floor | |
CY2024Q3 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | |
CY2024Q3 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2024Q3 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10036 | |
CY2024Q3 | dei |
City Area Code
CityAreaCode
|
(646) | |
CY2024Q3 | dei |
Local Phone Number
LocalPhoneNumber
|
828-8258 | |
CY2024Q3 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2024Q3 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q2 | INBS |
Deferred Charges
DeferredCharges
|
usd | |
CY2023Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
usd | |
CY2024Q3 | us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
usd | |
CY2024Q3 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
usd | |
CY2023Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
usd | |
CY2024Q3 | INBS |
Fair Value Gain On Revaluation Of Holdback Series Preferred Stock
FairValueGainOnRevaluationOfHoldbackSeriesPreferredStock
|
usd | |
CY2024Q3 | INBS |
Increase Decrease In Grant Receivable And Deferred Grant Income
IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome
|
usd | |
CY2023Q3 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
usd | |
CY2023Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | |
CY2023Q3 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
CY2023Q3 | INBS |
Equity Issuance Costs In Accounts Payable And Accrued Expenses
EquityIssuanceCostsInAccountsPayableAndAccruedExpenses
|
usd | |
CY2024Q3 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q3 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q3 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | |
CY2024Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q3 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q3 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2024Q3 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2024Q3 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4386816 | shares |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3989431 | usd |
CY2024Q3 | INBS |
Deferred Charges
DeferredCharges
|
127586 | usd |
CY2024Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
396193 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
6478911 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
586120 | usd |
CY2024Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
260760 | usd |
CY2024Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4400092 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
11725883 | usd |
CY2024Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1834416 | usd |
CY2024Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
281565 | usd |
CY2024Q3 | us-gaap |
Deferred Income Current
DeferredIncomeCurrent
|
2585696 | usd |
CY2024Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
477517 | usd |
CY2024Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
499605 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5678799 | usd |
CY2024Q3 | INBS |
Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
|
69731 | usd |
CY2024Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
28111 | usd |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4377759 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4377759 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3456000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3456000 | shares |
CY2024Q3 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
116 | shares |
CY2024Q2 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
116 | shares |
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
872287 | usd |
CY2024Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
525486 | usd |
CY2023Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
563763 | usd |
CY2024Q3 | us-gaap |
Gross Profit
GrossProfit
|
346801 | usd |
CY2023Q3 | us-gaap |
Gross Profit
GrossProfit
|
232331 | usd |
CY2024Q3 | us-gaap |
Government Assistance Operating Income
GovernmentAssistanceOperatingIncome
|
126128 | usd |
CY2023Q3 | us-gaap |
Government Assistance Operating Income
GovernmentAssistanceOperatingIncome
|
109871 | usd |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1949016 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2457060 | usd |
CY2024Q3 | INBS |
Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
|
948752 | usd |
CY2023Q3 | INBS |
Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
|
103947 | usd |
CY2024Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
300422 | usd |
CY2023Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
307560 | usd |
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
3198190 | usd |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2868567 | usd |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2725261 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2526365 | usd |
CY2024Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
22327 | usd |
CY2023Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
37448 | usd |
CY2024Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-51 | usd |
CY2023Q3 | us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
131250 | usd |
CY2024Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
52840 | usd |
CY2023Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
139 | usd |
CY2024Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
30462 | usd |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
93941 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2694799 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2432424 | usd |
CY2024Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-9166 | usd |
CY2023Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-7220 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2685633 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2425204 | usd |
CY2024Q3 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
216355 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-18016 | usd |
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
216355 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-18016 | usd |
CY2024Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-2478444 | usd |
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-2450440 | usd |
CY2024Q3 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-9166 | usd |
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-7220 | usd |
CY2024Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2469278 | usd |
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2443220 | usd |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.70 | |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.70 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-12.48 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-12.48 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3811090 | shares |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3811090 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
194200 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
194200 | shares |
CY2024Q1 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-12 | |
CY2024Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
8183191 | usd |
CY2024Q3 | INBS |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
7939 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
|
190045 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
12000 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
34511 | usd |
CY2024Q3 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
216355 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2694799 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
5949242 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3686998 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3686998 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-18016 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2432424 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1236558 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1236558 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-12 | |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2694799 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2432424 | usd |
CY2024Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
241622 | usd |
CY2023Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
247598 | usd |
CY2024Q3 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
61489 | usd |
CY2023Q3 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
59962 | usd |
CY2023Q3 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
67851 | usd |
CY2024Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
202045 | usd |
CY2024Q3 | INBS |
Non Cash Refund Of Research And Development Expenditure Claims
NonCashRefundOfResearchAndDevelopmentExpenditureClaims
|
86037 | usd |
CY2023Q3 | INBS |
Non Cash Refund Of Research And Development Expenditure Claims
NonCashRefundOfResearchAndDevelopmentExpenditureClaims
|
33523 | usd |
CY2023Q3 | INBS |
Fair Value Gain On Revaluation Of Holdback Series Preferred Stock
FairValueGainOnRevaluationOfHoldbackSeriesPreferredStock
|
-131250 | usd |
CY2024Q3 | INBS |
Noncash Other Operating Activities
NoncashOtherOperatingActivities
|
33170 | usd |
CY2023Q3 | INBS |
Noncash Other Operating Activities
NoncashOtherOperatingActivities
|
-104485 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
148874 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
273649 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-38748 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
53035 | usd |
CY2023Q3 | INBS |
Increase Decrease In Grant Receivable And Deferred Grant Income
IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome
|
97128 | usd |
CY2024Q3 | INBS |
Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
|
123002 | usd |
CY2023Q3 | INBS |
Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
|
60830 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
127586 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-101379 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-139486 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
221335 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
1215964 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
6116 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
2830 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-46482 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-68170 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2387216 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1311833 | usd |
CY2024Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
34511 | usd |
CY2024Q3 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
7939 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
42450 | usd |
CY2024Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
30099 | usd |
CY2023Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-39010 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2314667 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1350843 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
6304098 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1537244 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
3989431 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
186401 | usd |
CY2024Q3 | INBS |
Equity Issuance Costs In Accounts Payable And Accrued Expenses
EquityIssuanceCostsInAccountsPayableAndAccruedExpenses
|
127586 | usd |
CY2024Q3 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
3000000.0 | usd |
CY2024Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
34511 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
17167 | shares |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2685633 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2425204 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
5949242 | usd |
CY2024Q3 | INBS |
Working Capital Deficit
WorkingCapitalDeficit
|
800112 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-54649965 | usd |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3990000 | usd |
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
216355 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
18016 | usd |
CY2024Q3 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_840_eus-gaap--UseOfEstimates_z4heeXKYRzT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zKRxsjAcunhi">Use of estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates made by management in connection with the preparation of the accompanying consolidated financial statements including the fair value measurement of and the useful lives of long-lived assets, inventory valuations, the allocation of transaction price among various performance obligations, and the allowance for credit losses. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2024Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2024Q2 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2024Q3 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_z8a8Wh4PmW8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zewkmF9qwMUa">Concentration of credit risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company places its cash and cash equivalents, which may at times be in excess of the Australia Financial Claims Scheme, Financial Services Compensation Scheme or the United States’ Federal Deposit Insurance Corporation insurance limits, with high credit quality financial institutions and attempts to limit the amount of credit exposure with any one institution. No losses have been incurred to date on any deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> | |
CY2024Q3 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
0 | usd |
CY2023Q3 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
0 | usd |
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
872287 | usd |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
796094 | usd |
CY2021Q2 | us-gaap |
Deferred Income
DeferredIncome
|
4700000 | usd |
CY2024Q3 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
568678 | usd |
CY2024Q2 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
543410 | usd |
CY2024Q3 | INBS |
Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
|
110087 | usd |
CY2023Q3 | INBS |
Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
|
76348 | usd |
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
872287 | usd |
CY2024Q3 | us-gaap |
Government Assistance Operating Income
GovernmentAssistanceOperatingIncome
|
126128 | usd |
CY2024Q3 | us-gaap |
Revenues
Revenues
|
998415 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2694799 | usd |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
796094 | usd |
CY2023Q3 | us-gaap |
Government Assistance Operating Income
GovernmentAssistanceOperatingIncome
|
109871 | usd |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
905965 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2432424 | usd |
CY2024Q3 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
5246972 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
738789 | usd |
CY2024Q3 | INBS |
Long Lived Assets And Inventory
LongLivedAssetsAndInventory
|
5985761 | usd |
CY2024Q2 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
5244620 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
777537 | usd |
CY2024Q2 | INBS |
Long Lived Assets And Inventory
LongLivedAssetsAndInventory
|
6022157 | usd |
CY2024Q3 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
219050 | usd |
CY2024Q2 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
188693 | usd |
CY2024Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
519739 | usd |
CY2024Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
588844 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
738789 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
777537 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
5463000 | usd |
CY2024Q3 | INBS |
Effect Of Foreign Currency On Intangible Assets
EffectOfForeignCurrencyOnIntangibleAssets
|
998882 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2061790 | usd |
CY2024Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4400092 | usd |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
5463000 | usd |
CY2024Q2 | INBS |
Effect Of Foreign Currency On Intangible Assets
EffectOfForeignCurrencyOnIntangibleAssets
|
632878 | usd |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1723852 | usd |
CY2024Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4372026 | usd |
CY2024Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
235464 | usd |
CY2023Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
243153 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
703306 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
863222 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
838382 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
838382 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
838382 | usd |
CY2024Q3 | INBS |
Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
|
209596 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4291270 | usd |
CY2024Q3 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd |
CY2024Q3 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.0097 | pure |
CY2024Q3 | INBS |
Percentage Of Gross Revenue Received
PercentageOfGrossRevenueReceived
|
0.10 | pure |
CY2024Q3 | INBS |
Percentage Of Sales To Distributor
PercentageOfSalesToDistributor
|
0.50 | pure |
CY2024Q3 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
61489 | usd |
CY2023Q3 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
59962 | usd |
CY2024Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
12734 | usd |
CY2023Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
21171 | usd |
CY2024Q3 | us-gaap |
Lease Cost
LeaseCost
|
74223 | usd |
CY2023Q3 | us-gaap |
Lease Cost
LeaseCost
|
81133 | usd |
CY2024Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y1M6D | |
CY2024Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.132 | pure |
CY2024Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y3M18D | |
CY2024Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.132 | pure |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
246773 | usd |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
87990 | usd |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
334763 | usd |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
25087 | usd |
CY2024Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
309676 | usd |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
5516754 | shares |
CY2024Q3 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
3000000.0 | usd |
CY2024Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
34511 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
17167 | shares |
CY2024Q3 | us-gaap |
Stock Issued During Period Shares Employee Stock Ownership Plan
StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
|
99500 | shares |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
|
190045 | usd |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.91 | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2685633 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2425204 | usd |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.70 | |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.70 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-12.48 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-12.48 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3811090 | shares |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3811090 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
194200 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
194200 | shares |
CY2024Q3 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |